Insider Shareholders with Direct Ownership of Transcode Therapeutics, Inc. (RNAZ)
This section provides a comprehensive overview of the insiders with direct ownership of Transcode Therapeutics, Inc. (RNAZ). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Transcode Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Robert Michael Dudley
Chief Executive Officer |
185,607 | 0 | 180,262 $45,065 | 7 |
Sep 28, 2023
Added 35.22%
|
Thomas A Fitzgerald
Interim CEO, CFO |
61,350 | 0 | 56,318 $14,079 | 2 |
Sep 28, 2023
Added 46.7%
|